Abulateefeh Samer R, Alkawareek Mahmoud Y, Abdullah Fatema R, Alkilany Alaaldin M
Department of Pharmaceutics and Pharmaceutical Technology, School of Pharmacy, The University of Jordan, Amman 11942, Jordan.
Department of Pharmaceutics and Pharmaceutical Technology, School of Pharmacy, The University of Jordan, Amman 11942, Jordan.
J Pharm Sci. 2017 Apr;106(4):1136-1142. doi: 10.1016/j.xphs.2016.12.027. Epub 2017 Jan 3.
Previously, our group employed the internal phase separation method to produce aqueous core-PLGA [poly(d,l-lactide-co-glycolide)] shell microcapsules with polynuclear core morphologies. This report describes the preparation of the more desired and challenging architecture with mononuclear cores. Optimization of formulation parameters including (1) varying the composition of the internal phase and (2) incorporating selected organic solvents (dichloromethane, chloroform, methanol, and acetonitrile) into the internal phase was systematically evaluated. Varying the composition of the internal phase (i.e., PLGA and water levels) failed to produce mononuclear microcapsules. However, incorporating methanol or acetonitrile into the internal phase produced microcapsules with mononuclear cores as confirmed by phase-contrast microscopy, transmission electron microscopy, and scanning electron microscopy. Stability of the prepared emulsions (internal phase of PLGA, acetone, acetonitrile, and water) was optimized by evaluating different types of surfactants with varying concentrations. Among them, lecithin in the range of 0.5%-5% wt/wt provided the best emulsion stability. Interestingly, increasing lecithin concentrations led to the production of microcapsules with smaller sizes (from 2.4 ± 1.6 to 1.1 ± 0.8 μm) and higher percentage of mononuclear cores. The resulting aqueous core-PLGA shell microcapsules are expected to have interesting applications in drug delivery systems with controlled release for hydrophilic drugs and proteins.
此前,我们团队采用内相分离法制备了具有多核核形态的水相核-PLGA[聚(d,l-丙交酯-共-乙交酯)]壳微胶囊。本报告描述了更理想且更具挑战性的单核核结构的制备方法。系统评估了配方参数的优化,包括(1)改变内相组成,以及(2)向内相中加入选定的有机溶剂(二氯甲烷、氯仿、甲醇和乙腈)。改变内相组成(即PLGA和水的含量)未能制备出单核微胶囊。然而,向内相中加入甲醇或乙腈后,通过相差显微镜、透射电子显微镜和扫描电子显微镜证实制备出了具有单核核的微胶囊。通过评估不同类型、不同浓度的表面活性剂,优化了所制备乳液(PLGA、丙酮、乙腈和水的内相)的稳定性。其中,0.5%-5% wt/wt范围内的卵磷脂提供了最佳的乳液稳定性。有趣的是,增加卵磷脂浓度会导致制备出尺寸更小(从2.4±1.6μm至1.1±0.8μm)且单核核比例更高的微胶囊。所得的水相核-PLGA壳微胶囊有望在亲水性药物和蛋白质控释给药系统中具有有趣的应用。